Innovation
2 patent families (1 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 34 times.
| Year | Filings |
|---|---|
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |
Developer of RNA-targeting small molecules for untreatable diseases
2 patent families (1 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 34 times.
| Year | Filings |
|---|---|
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |